Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ilsung Pharmaceuticals
Seoul, South Korea
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Ilsung Pharmaceuticals has commercialized and approved products (e.g., Calcium Dobesilate for venous insufficiency) and has one discontinued program for Alzheimer disease. Their portfolio focuses on antibiotics, contrast media, anesthetics, CNS and cardiovascular therapeutics[1][2][3][4].
- Therapeutic areas
- EndocrinologyMetabolic DisordersOphthalmologyGastroenterologyCardiovascularNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
GSKAbbottOno PharmaceuticalTeijin
Beyond the preview
Go deeper on Ilsung Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ilsung Pharmaceuticals.